Topic: Life sciences and healthcare
Subscribe to Life sciences and healthcareFlexibility in the usage of foreign exchange in healthcare sector contracts
October 28, 2024
New regulation on Foreign Currency Contracts brings some flexibility in the prohibition of foreign currency-denominated and indexed contracts in the healthcare sector in Türkiye.
Doing Business in Türkiye in its ninth edition
February 12, 2024
Latest insights providing a comprehensive understanding of the Turkish business environment.
Doing Business in Turkey in its eighth edition
April 03, 2023
Norton Rose Fulbright and Pekin Bayar Mizrahi announce the 2023 update of the Legal Handbook for Doing Business in Turkey.
Norton Rose Fulbright advises on ADQ’s acquisition of Birgi Mefar Group
June 21, 2022
Norton Rose Fulbright advised the shareholders of Turkish pharmaceuticals company BMG on the sale of 100% of its shares to Abu Dhabi investment and holding company ADQ.
Energy Transition: Where to invest in 2022
March 02, 2022
Anne Lapierre, Global Head of Energy at Norton Rose Fulbright, joined a panel discussion on Energy transition: Where to invest in 2022.
New FCPA advisory opinion on forced payments
February 15, 2022
For businesses in Turkey and around the world, navigating increasingly complex FCPA regulations can be a challenge.
Norton Rose Fulbright announces alliance with Pekin Bayar Mizrahi in Turkey
October 22, 2021
Global law firm Norton Rose Fulbright has bolstered its client offering in Turkey by forming a new alliance with leading Turkish firm Pekin Bayar Mizrahi.
Turkey has extended R&D and design centers incentive program
March 29, 2021
According to data provided on the Ministry of Industry and Technology’s website, there are currently more than 1,500 research and development (R&D) and design centers employing more than 70,000 people in Turkey.
